Why did you decide to do a webinar with us?
Every organisation working in pulmonary drug delivery is facing the same challenge: how to move away from propellants such as hydrofluoroalkanes HFA P227 and HFA 134a towards newer, more environmentally friendly approaches aimed at further reducing the sector’s carbon footprint. This challenge must be overcome without losing sight of two fundamental priorities: ensuring patient safety and supporting regimen adherence.
Both Jag Sur (my co-presenter and CEO of Nanopharm) felt it important to review the key challenges involved in developing low carbon pMDIs and then explain how Aptar Pharma can support its partners programs by derisking and accelerating the development, scale-up and commercialization of inhalers with lower carbon footprints.
What will the audience gain from attending your webinar?
We will address the technical, regulatory, manufacturing and R&D considerations in delivering more sustainable alternatives.
How did you get into the industry and what do you most enjoy about your role?
I have been working in the field of inhalation drug delivery for over 30 years, gaining significant expertise in metering valve technologies for pressurised metered dose inhalers and their accessory/ peripheral device technologies, including dose indicators and breath-activated inhalers.
It gives me great satisfaction to know that the solutions we create make a tangible difference to the quality of life of millions of people around the world, every day.
What are you hoping to achieve in the future in your personal and professional life?
From a professional perspective, I would like to play an integral role in the redefining of the asthma inhaler landscape and see through the implementation of new, more sustainable propellant(s).
From a personal perspective, stay healthy, continue to run, cycle and compete in another Tough Viking event. Most importantly, continue to beat my two sons in our Lock-Down Olympics
Register now
AM Session – https://bit.ly/3wtRxJl
PM Session – https://bit.ly/3pTVrsL